LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹176 Cr | ₹157 Cr | ₹152 Cr | ₹186 Cr | ₹174 Cr |
What is the latest Total Liabilities ratio of LYKA LABS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹176 Cr |
Mar2024 | ₹157 Cr |
Mar2023 | ₹152 Cr |
Mar2022 | ₹186 Cr |
Mar2021 | ₹174 Cr |
How is Total Liabilities of LYKA LABS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹176 Cr | 12.34 | |
Mar2024 | ₹157 Cr | 3.52 | |
Mar2023 | ₹152 Cr | -18.37 | |
Mar2022 | ₹186 Cr | 6.88 | |
Mar2021 | ₹174 Cr | - |
Compare Total Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹415.5 Cr | 6.3% | 1.9% | -7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 6.3% |
1.9% |
-7% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses